Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

You are currently viewing Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

Call 14 of the Innovative Medicines Initiative (IMI) is now open with topics on immune diseases, imaging, machine learning and digital clinical trials

The Innovative Medicines Initiative (IMI) is a partnership between the European Union and the European pharmaceutical industry.

Call ID:   H2020-JTI-IMI2-2018-14-two-stage

Topics

• Topic 1: Targeted immune intervention for the management of non-response and relapse

• Topic 2: Non-invasive clinical molecular imaging of immune cells

• Topic 3: Development of a platform for federated and privacy-preserving machine learning in support of drug discovery

• Topic 4: Centre of excellence – remote decentralised clinical trials

Stage 1 submission deadline: 14 June 2018

Read on: https://www.imi.europa.eu/apply-funding/open-calls/imi2-call-14